20.30
-0.49(-2.36%)
Currency In CNY
Address
Building C, Yingdu Building
Beijing, 100086
China
Phone
86 10 5873 1516
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
439
First IPO Date
December 12, 2016
| Name | Title | Pay | Year Born |
| Huaming Jiang | Deputy General Manager | 0 | 1968 |
| Jing Sheng Cui | Deputy General Manager | 0 | 1987 |
| Lian Yang | Deputy General Manager | 0 | 1979 |
| Ying Gao | Deputy General Manager | 0 | 1984 |
| Qianjin Li | Deputy GM & Secretary of the Board of Directors | 0 | 1977 |
| Yongxiang Zhang | Accounting Supervisor | 0 | N/A |
| Zhou Min | GM, Chief Financial Officer & Director | 0 | 1987 |
Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain; Carbetocin injections; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotic, antiallergic, and digestive system. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.